Centrosome amplification, chromosome instability and cancer development

Cancer Letters

Volumn 230, Issue 1, 2005, Pages 6-19

  Fukasawa, Kenji ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Aneuploidy; BRCA1; BRCA2; Cancer; CDK2; Cell cycle; Centrosome; Chromosome instability; Cyclin E; DAN repair; Mitosis; p21; p53; Rad51

Indexed keywords

BRCA1 PROTEIN; CYCLIN E; CYTARABINE; FLUOROURACIL; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

CARCINOGENESIS; CELL CYCLE; CELL CYCLE S PHASE; CELL FUNCTION; CELL STRUCTURE; CELL TRANSFORMATION; CENTROSOME; CHROMOSOMAL INSTABILITY; CYTOKINESIS; DNA DAMAGE; DRUG DESIGN; DRUG TARGETING; GENE AMPLIFICATION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SHORT SURVEY;

EID: 27144540976     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.12.028     Document Type: Review

References (88)

1. L. Foulds The experimental study of tumor progression: a review Cancer Res. 14 1954 327 339
2. P. Nowell The clonal evolution of tumor cell populations Science 194 1976 23 28
3. L.A. Loeb Mutator phenotype may be required for multistage carcinogenesis Cancer Res. 51 1991 3075 3079
4. S. Doxsey The centrosome - a tiny organelle with big potential Nat. Genet. 20 1998 104 106
5. A.B. D'Assoro, W.L. Lingle, and J.L. Salisbury Centrosome amplification and the development of cancer Oncogene 21 2002 6146 6153
6. M. Paintrand, M. Moudjou, H. Delacroix, and M. Bornens Centrosome organization and centriole architecture: their sensitivity to divalent cations J. Struct. Biol. 108 1992 107 128
7. M. Bornens Centrosome composition and microtubule anchoring mechanisms Curr. Opin. Cell Biol. 14 2002 25 34
8. D. Mazia The chromosome cycle and the centrosome cycle in the mitotic cycle Int. Rev. Cytol. 100 1987 49 92
9. V. Dulic, E. Lees, and S.I. Reed Association of human cyclin E with a periodic G1-S phase protein kinase Science 257 1992 1958 1961
10. A. Koff, A. Giordano, D. Desai, K. Yamashita, J.W. Harper, and S. Elledge Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle Science 257 1992 1689 1694
11. J.W. Harper Cyclin dependent kinase inhibitors Cancer Surv. 29 1997 91 107
12. J.G. Mussman, H.F. Horn, P.E. Carroll, M. Okuda, L.A. Donehower, and K. Fukasawa Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression Oncogene 19 2000 1635 1946
13. A.C. Minella, J. Swanger, E. Bryant, M. Welcker, H. Hwang, and B.E. Clurman p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation Curr. Biol. 12 2002 1817 1827
14. J.R. Nevins E2F: a link between the Rb tumor suppressor protein and viral oncoproteins Science 258 1992 424 429
15. E.H. Hinchcliffe, C. Li, E.A. Thompson, J.L. Maller, and G. Sluder Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts Science 283 1999 851 854
16. K.R. Lacey, P.K. Jackson, and T. Stearns Cyclin-dependent kinase control of centrosome duplication Proc. Natl Acad. Sci. USA 96 1999 2817 2822
17. Y. Matsumoto, K. Hayashi, and E. Nishida Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells Curr. Biol. 9 1999 429 432
18. P. Tarapore, M. Okuda, and K. Fukasawa A mammalian in vitro centriole duplication system: evidence for involvement of CDK2/cyclin E and nucleophosmin/B23 in centrosome duplication Cell Cycle 1 2002 75 81
19. M. Okuda, H.F. Horn, P. Tarapore, Y. Tokuyama, A.G. Smulian, and P.-K. Chan Nucleophosmin/B23 is a target of CDK2-cyclin E in centrosome duplication Cell 103 2000 127 140
20. H.A. Fisk, and M. Winey The mouse Mps1p-like kinase regulates centrosome duplication Cell 106 2001 95 104
21. Z. Chen, V.B. Indjeian, M. McManus, L. Wang, and B.D. Dynlacht CP110, a cell cycle-dependent CDK substrate, regulates centrosome duplication in human cells Dev. Cell 3 2002 339 350
22. Y. Uetake, and G. Sluder Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a 'tetraploidy checkpoint' J. Cell Biol. 165 2004 609 615
23. M. Forgues, M.J. Difilippantonio, S.P. Linke, T. Ried, K. Nagashima, and J. Feden Involvement of Crm1 in hepatitis B virus X protein-induced aberrant centriole replication and abnormal mitotic spindles Mol. Cell. Biol. 23 2003 5282 5292
24. H.M. Hut, W. Lemstra, E.H. Blaauw, G.W. Van Cappellen, H.H. Kampinga, and O.C. Sibon Centrosomes split in the presence of impaired DNA integrity during mitosis Mol. Biol. Cell 14 2003 1993 2004
25. A. Khodjakov, C.L. Rieder, G. Sluder, G. Cassels, O. Sibon, and C.L. Wang De novo formation of centrosomes in vertebrate cells arrested during S phase J. Cell Biol. 158 2002 1171 1181
26. D.L. Gard Organization, nucleation, and acetylation of microtubules in Xenopus laevis oocytes: a study by confocal immunofluorescence microscopy Dev. Biol. 143 1991 346 362
27. G.A. Pihan, A. Purohit, J. Wallace, H. Knecht, B. Woda, P. Quesenberry, and S.J. Doxsey Centrosome defects and genetic instability in malignant tumors Cancer Res. 58 1998 3974 3985
28. P.E. Carroll, M. Okuda, H.F. Horn, P. Biddinger, P.J. Stambrook, and L.L. Gleich Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression Oncogene 18 1999 1935 1944
29. W.L. Lingle, and J.L. Salisbury Altered centrosome structure is associated with abnormal mitoses in human breast tumors Am. J. Pathol. 155 1999 1941 1951
30. W.L. Lingle, S.L. Barrett, V.C. Negron, A.B. D'Assoro, K. Boeneman, and W. Liu Centrosome amplification drives chromosomal instability in breast tumor development Proc. Natl Acad. Sci. USA 99 2002 1978 1983
31. K. Kawamura, M. Moriyama, N. Shiba, M. Ozaki, T. Tanaka, and T. Nojima Centrosome hyperamplification and chromosomal instability in bladder cancer Eur. Urol. 43 2003 505 515
32. F. Jiang, N.P. Caraway, A.L. Sabichi, H.Z. Zhang, A. Ruitrok, and H.B. Grossman Centrosomal abnormality is common in and a potential biomarker for bladder cancer Int. J. Cancer 106 2003 661 665
33. K. Kawamura, H. Izumi, Z. Ma, R. Ikeda, M. Moriyama, and T. Tanaka Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression Cancer Res. 64 2004 4800 4809
34. R.G. Weber, J.M. Bridger, A. Benner, D. Weisenberger, V. Ehemann, G. Reifenberger, and P. Lichter Centrosome amplification as a possible mechanism for numerical chromosome aberrations in cerebral primitive neuroectodermal tumors with TP53 mutations Cytogenet. Cell Genet. 83 1998 266 269
35. K. Al-Romaih, J. Bayani, J. Vorobyova, J. Karaskova, P.C. Park, M. Zielenska, and J.A. Squire Chromosomal instability in osteosarcoma and its association with centrosome abnormalities Cancer Genet. Cytogenet. 144 2003 91 99
36. D. Gisselsson, E. Palsson, C. Yu, F. Mertens, and N. Mandahl Mitotic instability associated with late genomic changes in bone and soft tissue tumours Cancer Lett. 206 2004 69 76
37. T. Nakajima, M. Moriguchi, Y. Mitsumoto, S. Sekoguchi, T. Nishikawa, and H. Takashima Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma Mod. Pathol. 17 2004 722 727
38. G.A. Pihan, A. Purohit, J. Wallace, R. Malhotra, L. Liotta, and S.J. Doxsey Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression Cancer Res. 61 2001 2212 2219
39. N. Sato, K. Mizumoto, M. Nakamura, K. Nakamura, M. Kusumoto, and H. Niiyama Centrosome abnormalities in pancreatic ductal carcinoma Clin. Cancer Res. 5 1999 963 970
40. L.C. Hsu, M. Kapali, J.A. Deloia, H.H. Gallion, Centrosome abnormalities in ovarian cancer, Int. J. Cancer 113 (2005) 746-751.
41. F. Mayer, H. Stoop, S. Sen, C. Bokemeyer, J.W. Oosterhuis, and L.H. Looijenga Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes Oncogene 22 2003 3859 3866
42. B. Skyldberg, K. Fujioka, A.C. Hellstrom, L. Sylven, B. Moberger, and G. Auer Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions Mod. Pathol. 14 2001 279 284
43. K.K. Kuo, N. Sato, K. Mizumoto, N. Maehara, H. Yonemasu, and C.G. Ker Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic and extrahepatic bile ducts Hepatology 31 2000 59 64
44. L. Roshani, K. Fujioka, G. Auer, M. Kjellman, S. Lagercrantz, and C. Larsson Aberrations of centrosomes in adrenocortical tumors Int. J. Oncol. 20 2002 1161 1165
45. L.M. Gustafson, L.L. Gleich, K. Fukasawa, J. Chadwell, M.A. Miller, P.J. Stambrook, and J.L. Gluckman Centrosome hyperamplification in head and neck squamous cell carcinoma: a potential phenotypic marker of tumor aggressiveness Laryngoscope 110 2000 1798 1801
46. K. Neben, B. Tews, G. Wrobel, M. Hahn, F. Kokocinski, and C. Giesecke Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes Oncogene 23 2004 2379 2384
47. K. Neben, C. Giesecke, S. Schweizer, A.D. Ho, and A. Kramer Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile Blood 23 2003 2379 2384 (Epub 2002 Jun 28)
48. A. Kramer, S. Schweizer, K. Neben, C. Giesecke, J. Kalla, and T. Katzenberger Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma Leukemia 17 2003 2207 2213
49. K. Fukasawa, T. Choi, R. Kuriyama, S. Rulong, and G.F. Vande Woude Abnormal amplification of centrosomes and genetic instability in the absence of p53 Science 271 1996 1744 1747
50. K. Fukasawa, F. Wiener, G.F. Vande Woude, and S. Mai Genome destabilization by the loss of p53 and c-Myc overexpression Oncogene 15 1997 1295 1302
51. R. Balczon, L. Bao, W.E. Zimmer, K. Brown, R.P. Zinkowski, and B.R. Brinkley Dissociation of centrosome replication events from cycles of DNA synthesis and mitotic division in hydroxyurea-arrested Chinese hamster ovary cells J. Cell Biol. 130 1995 105 115
52. Waf1/Cip1 pathway Oncogene 20 2001 3173 3184
53. B.K. Nayak, and G.M. Das Stabilization of p53 and transactivation of its target genes in response to replication blockade Oncogene 21 2002 7226 7229
54. C. Wong, T. Stearns, Centrosome number is controlled by a centrosome-intrinsic block to re-duplication, Nat. Cell Biol. 5 (2003) 539-544.
55. X.J. Wang, D.A. Greenhalgh, A. Jiang, D. He, L. Zhong, B.R. Brinkley, and D.R. Roop Analysis of centrosome abnormalities and angiogenesis in epidermal-targeted p53 172H mutant and p53-knockout mice after chemical carcinogenesis: evidence for a gain of function Mol. Carcinog. 23 1998 185 192
56. S. Duensing, L.Y. Lee, A. Duensing, J. Basile, S. Piboonniyom, and S. Gonzalez The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle Proc. Natl Acad. Sci. USA 97 2000 10002 10007
57. F. Bunz, C. Fauth, M.R. Speicher, A. Dutriaux, J.M. Sedivy, and K.W. Kinzler Targeted inactivation of p53 in human cells does not result in aneuploidy Cancer Res. 62 2002 1129 1133
58. J. Botz, K. Zerfass-Thome, D. Spitkovsky, H. Delius, B. Vogt, and M. Eilers Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter Mol. Cell. Biol. 16 1996 3401 3409
59. S.V. Ekholm, P. Zickert, S.I. Reed, and A. Zetterberg Accumulation of cyclin E is not a prerequisite for passage through the restriction point Mol. Cell. Biol. 21 2001 3256 3265
60. K. Keyomarsi, and T.W. Herliczek The role of cyclin E in cell proliferation, development and cancer Prog. Cell Cycle Res. 3 1997 171 191
61. P. Karakaidos, S. Taraviras, L.V. Vassiliou, P. Zacharatos, N.G. Kastrinakis, and D. Kougiou Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability - evidence of E2F-1 transcriptional control over hCdt1 Am. J. Pathol. 165 2004 1165 1351
62. M. Furihata, Y. Ohtsuki, H. Sonobe, T. Shuin, A. Yamamoto, N. Terao, and M. Kuwahara Prognostic significance of cyclin E and p53 protein overexpression in carcinoma of the renal pelvis and ureter Br. J. Cancer 77 1998 783 788
63. T. Sakaguchi, A. Watanabe, H. Sawada, Y. Yamada, J. Yamashita, and M. Matsuda Prognostic value of cyclin E and p53 expression in gastric carcinoma Cancer 82 1998 1238 1243
64. Y. Miki, J. Swensen, D. Shattuck-Eidens, P.A. Futreal, K. Harshman, and S. Tavtigian A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
65. X. Xu, Z. Weaver, S.P. Linke, C. Li, J. Gotay, and X.W. Wang Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells Mol. Cell 3 1999 389 395
66. R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, and J. Mangion Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789 792
67. A. Tutt, A. Gabriel, D. Bertwistle, F. Connor, H. Paterson, and J. Peacock Absence of Brca2 causes genomic instability by chromosome breakage and loss associated with centrosome amplification Curr. Biol. 9 1999 1107 1110
68. M.E. Moynahan, J.W. Chiu, B.H. Koller, and M. Jasin Brca1 controls homology-directed DNA repair Mol. Cell 4 1999 511 518
69. C.X. Deng, and R.H. Wang Roles of BRCA1 in DNA damage repair: a link between development and cancer Hum. Mol. Genet. 12 2003 113 123
70. T.K. MacLachlan, R. Takimoto, and W.S. El-Deiry BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets Mol. Cell. Biol. 22 2002 4280 4292
71. P.L. Welcsh, M.K. Lee, R.M. Gonzalez-Hernandez, D.J. Black, M. Mahadevappa, and E.M. Swisher BRCA1 transcriptionally regulates genes involved in breast tumorigenesis Proc. Natl Acad. Sci. USA 99 2002 7560 7565
72. D.A. Bochar, L. Wang, H. Beniya, A. Kinev, Y. Xue, and W.S. Lane BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer Cell 21 2000 257 265
73. R. Baer, and T. Ludwig The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity Curr. Opin. Genet. Dev. 12 2002 86 91
74. P. Kerr, and A. Ashworth New complexities for BRCA1 and BRCA2 Curr. Biol. 11 2001 668 676
75. M.H. Moynahan The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans Oncogene 21 2002 8994 9007
76. R. Mizuta, J.M. LaSalle, H.L. Cheng, A. Shinohara, H. Ogawa, and N. Copeland RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein Proc. Natl Acad. Sci. USA 94 1997 6927 6932
77. R. Scully, J. Chen, A. Plug, Y. Xiao, D. Weaver, and J. Feunteun Association of BRCA1 with Rad51 in mitotic and meiotic cells Cell 88 1997 265 275
78. S.K. Sharan, M. Morimatsu, U. Albrecht, D.S. Lim, E. Regel, and C. Dinh Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2 Nature 386 1997 804 810
79. A.K. Wong, R. Pero, P.A. Ormonde, S.V. Tavtigian, and P.L. Bartel RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2 J. Biol. Chem. 272 1997 31941 31944
80. P. Baumann, F.E. Benson, and S.C. West Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro Cell 87 1996 757 766
81. P. Bertrand, S. Lambert, C. Joubert, and B.S. Lopez Overexpression of mammalian Rad51 does not stimulate tumorigenesis while a dominant-negative Rad51 affects centrosome fragmentation, ploidy and stimulates tumorigenesis, in p53-defective CHO cells Oncogene 22 2003 7587 7592
82. H. Dodson, E. Bourke, L.J. Jeffers, P. Vagnarelli, E. Sonoda, and S. Takeda Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM Eur. Mol. Biol. Org. J. 23 2004 3864 3873
83. B. Deans, C.S. Griffin, P. O'Regan, M. Jasin, and J. Thacker Homologous recombination deficiency leads to profound genetic instability in cells derived from Xrcc2-knockout mice Cancer Res. 63 2003 8181 8187
84. N. Sato, K. Mizumoto, M. Nakamura, and M. Tanaka adiation-induced centrosome overduplication and multiple mitotic spindles in human tumor cells Exp. Cell Res. 255 2000 321 326
85. S. Heim, N. Mandahl, and F. Mitelman Genetic convergence and divergence in tumor progression Cancer Res. 48 1988 5911 5916
86. -/- cells in prolonged culture Exp. Cell Res. 258 2000 310 321
87. D. Ring, R. Hubble, and M. Kirschner Mitosis in a cell with multiple centrioles J. Cell Biol. 94 1982 549 556
88. R.A. Bennet, H. Izumi, and K. Fukasawa Induction of centrosome amplification and chromosome instability in p53-null cells by transient exposure to sub-toxic levels of S-phase targeting anti-cancer drugs Oncogene 23 2004 6823 6829